Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human BCO1, N-His

Recombinant Human BCO1, N-His from ProteoGenix; catalogue ARO-P12903; research use only.

SKU:
ABM143341-1
Manufacturer SKU
ARO-P12903
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant human BCO1 (Beta-Carotene Oxygenase 1) is a key enzyme involved in the metabolism of beta-carotene, a dietary source of vitamin A. This enzyme is encoded by the BCO1 gene and is primarily expressed in the liver and intestine. Recombinant human BCO1 has gained significant attention in the scientific community due to its potential therapeutic and industrial applications. In this article, we will discuss the structure, activity and application of recombinant human BCO1 in detail.

Structure of Recombinant Human BCO1

Recombinant human BCO1 is a 63 kDa protein consisting of 575 amino acids. It belongs to the carotenoid oxygenase family and has a conserved catalytic domain with a characteristic di-iron binding motif. The crystal structure of recombinant human BCO1 has been determined, revealing a unique fold with a central beta-sheet surrounded by alpha-helices. This structure is highly conserved across different species, indicating the importance of BCO1 in beta-carotene metabolism.

Activity of Recombinant Human BCO1

Recombinant human BCO1 acts as a key enzyme in the conversion of beta-carotene to retinol, the active form of vitamin A. This process involves the cleavage of beta-carotene into two molecules of retinal, which is then reduced to retinol by retinol dehydrogenase. The activity of recombinant human BCO1 is dependent on the presence of oxygen and iron ions, which act as cofactors in the catalytic reaction. Studies have shown that the activity of recombinant human BCO1 can be modulated by various factors such as pH, temperature, and substrate concentration.

Application of Recombinant Human BCO1

Therapeutic Applications

Recombinant human BCO1 has potential therapeutic applications in the treatment of vitamin A deficiency and related diseases. Deficiency of vitamin A is a major global health problem, especially in developing countries. Recombinant human BCO1 can be used to produce retinol, which can then be used as a dietary supplement to combat vitamin A deficiency. In addition, studies have shown that recombinant human BCO1 can also be used to produce retinoids, which have been used in the treatment of various diseases such as cancer, skin disorders, and eye diseases.

Industrial Applications

Recombinant human BCO1 also has potential industrial applications in the food and feed industry. Beta-carotene is a widely used food additive for its antioxidant and colorant properties. However, its low bioavailability limits its application. Recombinant human BCO1 can be used to enhance the bioavailability of beta-carotene by converting it to retinol, which is more easily absorbed by the body. This can lead to the development of functional foods with increased nutritional value. In addition, recombinant human BCO1 can also be used in the production of animal feed to improve the vitamin A status of livestock.

Research Applications

Recombinant human BCO1 is a valuable tool for research in the field of carotenoid metabolism. It can be used to study the role of BCO1 in various physiological processes and to understand the mechanisms underlying vitamin A deficiency and related diseases. Recombinant human BCO1 can also be used to screen for potential inhibitors or activators of the enzyme, which can aid in the development of novel therapeutics.

Conclusion

In conclusion, recombinant human BCO1 is a crucial enzyme involved in the metabolism of beta-carotene and has significant potential in various

ProteoGenix catalogue number ARO-P12903. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 25.25 kDa; Fragment: Gly6-Pro206; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
BCMO1, Beta,beta-carotene 15,15'-dioxygenase, BCDO, BCO1, Beta-carotene oxygenase 1, BCDO1, Beta-carotene dioxygenase 1
Host species
E. coli
Source organism
Human
Molecular weight
25.25 kDa
Sequence fragment
Gly6-Pro206
Sequence
GRNRKEQLEPVRAKVTGKIPAWLQGTLLRNGPGMHTVGESRYNHWFDGLALLHSFTIRDGEVYYRSKYLRSDTYNTNIEANRIVVSEFGTMAYPDPCKNIFSKAFSYLSHTIPDFTDNCLINIMKCGEDFYATSETNYIRKINPQTLETLEKVDYRKYVAVNLATSHPHYDEAGNVLNMGTSIVEKGKTKYVIFKIPATVP
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P12903
UniProt accession
Q9HAY6
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£229.00£183.20